{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:01:55Z","timestamp":1786946515467,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jns.2022.120267","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T21:12:23Z","timestamp":1650489143000},"page":"120267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Neuro-ophthalmological manifestations of Wolfram syndrome: Case series and review of the literature"],"prefix":"10.1016","volume":"437","author":[{"given":"Anna","family":"Kabanovski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Margolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2022.120267_bb0005","first-page":"715","article-title":"Diabetes mellitus and simple optic atrophy among siblings","volume":"13","author":"Wolfram","year":"1938","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jns.2022.120267_bb0010","doi-asserted-by":"crossref","unstructured":"Pallotta MT, Tascini G, Crispoldi R, Orabona C, Mondanelli G, Grohmann U, Esposito S. Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives. J. Transl. Med. 2019;17(1):238.3.","DOI":"10.1186\/s12967-019-1993-1"},{"issue":"Pt 6","key":"10.1016\/j.jns.2022.120267_bb0015","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/eye.1997.226","article-title":"Optic atrophy in Wolfram (DIDMOAD) syndrome","volume":"11","author":"Barrett","year":"1997","journal-title":"Eye (Lond.)"},{"issue":"3","key":"10.1016\/j.jns.2022.120267_bb0020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/jmg.14.3.190","article-title":"Diabetes mellitus, diabetes insipidus, and optic atrophy. An autosomal recessive syndrome?","volume":"14","author":"Fraser","year":"1977","journal-title":"J. Med. Genet."},{"issue":"4","key":"10.1016\/j.jns.2022.120267_bb0025","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.exer.2009.05.007","article-title":"Expression of the diabetes risk gene wolframin (WFS1) in the human retina","volume":"89","author":"Schmidt-Kastner","year":"2009","journal-title":"Exp. Eye Res."},{"issue":"5","key":"10.1016\/j.jns.2022.120267_bb0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaapos.2014.07.162","article-title":"Ophthalmologic correlates of disease severity in children and adolescents with Wolfram syndrome","volume":"18","author":"Hershey","year":"2014","journal-title":"J. AAPOS"},{"issue":"7","key":"10.1016\/j.jns.2022.120267_bb0035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/gim.2012.180","article-title":"Genotypic classification of patients with Wolfram syndrome: insights into the natural history of the disease and correlation with phenotype","volume":"15","author":"de Heredia","year":"2013","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.jns.2022.120267_bb0040","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12020-018-1608-2","article-title":"Natural history and clinical characteristics of 50 patients with Wolfram syndrome","volume":"61","author":"Bueno","year":"2018","journal-title":"Endocrine."},{"issue":"2","key":"10.1016\/j.jns.2022.120267_bb0045","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s12020-020-02320-6","article-title":"Wolfram syndrome: clinical and genetic profiling of a cohort from a tertiary care Centre with characterization of the primary gonadal failure","volume":"69","author":"Das","year":"2020","journal-title":"Endocrine."},{"issue":"2","key":"10.1016\/j.jns.2022.120267_bb0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000490535","article-title":"Ophthalmologic manifestations of Wolfram syndrome: report of 14 cases","volume":"241","author":"Soares","year":"2019","journal-title":"Ophthalmologica."},{"issue":"9","key":"10.1016\/j.jns.2022.120267_bb0055","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ophtha.2016.05.036","article-title":"WFS1 in optic neuropathies: mutation findings in nonsyndromic optic atrophy and assessment of clinical severity","volume":"123","author":"Grenier","year":"2016","journal-title":"Ophthalmology."},{"issue":"9","key":"10.1016\/j.jns.2022.120267_bb0060","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2337\/dc07-0380","article-title":"Microvascular diabetes complications in Wolfram syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness [DIDMOAD]): an age- and duration-matched comparison with common type 1 diabetes","volume":"30","author":"Cano","year":"2007","journal-title":"Diabetes Care"},{"issue":"3\u20134","key":"10.1016\/j.jns.2022.120267_bb0065","first-page":"433","article-title":"Three cases of Wolfram syndrome with different clinical aspects","volume":"28","author":"\u00c7amtosun","year":"2015","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jns.2022.120267_bb0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12020-019-02004-w","article-title":"Clinical and molecular assessment of 13 Iranian families with Wolfram syndrome","volume":"66","author":"Sobhani","year":"2019","journal-title":"Endocrine."},{"issue":"8988","key":"10.1016\/j.jns.2022.120267_bb0075","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S0140-6736(95)92473-6","article-title":"Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome","volume":"346","author":"Barrett","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jns.2022.120267_bb0080","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1210\/jc.2002-030015","article-title":"Diabetes mellitus and optic atrophy: a study of Wolfram syndrome in the Lebanese population","volume":"89","author":"Medlej","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.jns.2022.120267_bb0085","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.3174\/ajnr.A6831","article-title":"Longitudinal assessment of Neuroradiologic features in Wolfram syndrome","volume":"41","author":"Samara","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.jns.2022.120267_bb0090","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.1038\/s41598-019-42447-9","article-title":"Evidence for altered neurodevelopment and neurodegeneration in Wolfram syndrome using longitudinal morphometry","volume":"9","author":"Lugar","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jns.2022.120267_bb0095","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ana.22160","article-title":"Neurologic features and genotype-phenotype correlation in Wolfram syndrome","volume":"69","author":"Chaussenot","year":"2011","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2022.120267_bb0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaapos.2014.07.162","article-title":"Ophthalmologic correlates of disease severity in children and adolescents with Wolfram syndrome","volume":"18","author":"Hoekel","year":"2014","journal-title":"J. AAPOS"},{"issue":"1","key":"10.1016\/j.jns.2022.120267_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2017-000081","article-title":"Visual pathway function and structure in Wolfram syndrome: patient age, variation and progression","volume":"3","author":"Hoekel","year":"2018","journal-title":"BMJ Open Ophthalmol."},{"issue":"7","key":"10.1016\/j.jns.2022.120267_bb0110","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.ophtha.2016.01.007","article-title":"Lamination of the outer plexiform layer in optic atrophy caused by dominant WFS1 mutations","volume":"123","author":"Majander","year":"2016","journal-title":"Ophthalmology."},{"issue":"3","key":"10.1016\/j.jns.2022.120267_bb0115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/dmcn.14040","article-title":"Optical coherence tomography and magnetic resonance imaging visual pathway evaluation in Wolfram syndrome","volume":"61","author":"Zmyslowska","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"issue":"2","key":"10.1016\/j.jns.2022.120267_bb0120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/ICU.0b013e328343c1a3","article-title":"Neuro-ophthalmic disease and optical coherence tomography: glaucoma look-alikes","volume":"22","author":"Pasol","year":"2011","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jns.2022.120267_bb0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12883-015-0268-6","article-title":"Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"15","author":"Liu","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2022.120267_bb0130","article-title":"Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis","volume":"9","author":"Yu","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jns.2022.120267_bb0135","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.2337\/dc14-1898","article-title":"Retinal thinning as a marker of disease progression in patients with Wolfram syndrome","volume":"38","author":"Zmyslowska","year":"2015","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.jns.2022.120267_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040604","article-title":"Washington University Wolfram Study Group. Early brain vulnerability in Wolfram syndrome","volume":"7","author":"Hershey","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jns.2022.120267_bb0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/13816810.2018.1551494","article-title":"Evidence of retinal degeneration in Wolfram syndrome","volume":"40","author":"Scaramuzzi","year":"2019","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.jns.2022.120267_bb0150","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajo.2020.04.012","article-title":"Corneal abnormalities are novel clinical feature in Wolfram syndrome","volume":"217","author":"Waszczykowska","year":"2020","journal-title":"Am J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.jns.2022.120267_bb0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/13816810.2010.516056","article-title":"Congenital cataracts in two siblings with Wolfram syndrome","volume":"31","author":"Mets","year":"2010","journal-title":"Ophthalmic Genet."},{"issue":"5","key":"10.1016\/j.jns.2022.120267_bb0160","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1177\/1120672119842489","article-title":"Ophthalmic, systemic, and genetic characteristics of patients with Wolfram syndrome","volume":"30","author":"Ustaoglu","year":"2020","journal-title":"Eur. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.jns.2022.120267_bb0165","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1038\/s41598-020-61735-3","article-title":"Calcium mishandling in absence of primary mitochondrial dysfunction drives cellular pathology in Wolfram syndrome","volume":"10","author":"La Morgia","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2022.120267_bb0170","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41419-018-0406-3","article-title":"Wolfram syndrome: MAMs\u2019 connection?","volume":"9","author":"Delprat","year":"2018","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.jns.2022.120267_bb0175","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/hmg\/ddx060","article-title":"A novel CISD2 mutation associated with a classical Wolfram syndrome phenotype alters Ca2+ homeostasis and ER-mitochondria interactions","volume":"26","author":"Rouzier","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.jns.2022.120267_bb0180","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.mito.2013.05.013","article-title":"Optic nerve histopathology in a case of Wolfram syndrome: a mitochondrial pattern of axonal loss","volume":"13","author":"Ross-Cisneros","year":"2013","journal-title":"Mitochondrion."},{"issue":"1","key":"10.1016\/j.jns.2022.120267_bb0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12881-020-0950-4","article-title":"Clinical and genetic analysis of two wolfram syndrome families with high occurrence of wolfram syndrome and diabetes type II: a case report","volume":"21","author":"Sobhani","year":"2020","journal-title":"BMC Med. Genet."},{"issue":"3","key":"10.1016\/j.jns.2022.120267_bb0190","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/s41390-019-0487-4","article-title":"Wolfram syndrome 1 in the Italian population: genotype-phenotype correlations","volume":"87","author":"Rigoli","year":"2020","journal-title":"Pediatr. Res."},{"issue":"5","key":"10.1016\/j.jns.2022.120267_bb0195","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/jmg.2005.034892","article-title":"Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene","volume":"43","author":"Eiberg","year":"2006","journal-title":"J. Med. Genet."},{"issue":"6","key":"10.1016\/j.jns.2022.120267_bb0200","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/ajmg.a.33970","article-title":"Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment","volume":"155A","author":"Rendtorff","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"issue":"10","key":"10.1016\/j.jns.2022.120267_bb0205","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1007\/s00125-018-4690-3","article-title":"Identification of a missense variant in the WFS1 gene that causes a mild form of Wolfram syndrome and is associated with risk for type 2 diabetes in Ashkenazi Jewish individuals","volume":"61","author":"Bansal","year":"2018","journal-title":"Diabetologia."},{"issue":"1","key":"10.1016\/j.jns.2022.120267_bb0210","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11892-015-0702-6","article-title":"Wolfram syndrome: diagnosis, management, and treatment","volume":"16","author":"Urano","year":"2016","journal-title":"Curr. Diab. Rep."},{"issue":"49","key":"10.1016\/j.jns.2022.120267_bb0215","doi-asserted-by":"crossref","first-page":"E5292","DOI":"10.1073\/pnas.1421055111","article-title":"A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome","volume":"111","author":"Lu","year":"2014","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"issue":"15","key":"10.1016\/j.jns.2022.120267_bb0220","article-title":"A phase Ib\/IIa clinical trial of dantrolene sodium in patients with Wolfram syndrome","volume":"6","author":"Abreu","year":"2021","journal-title":"JCI Insight."},{"issue":"10","key":"10.1016\/j.jns.2022.120267_bb0225","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1210\/jc.2016-2240","article-title":"GLP-1-RA corrects mitochondrial labile Iron accumulation and improves \u03b2-cell function in type 2 Wolfram syndrome","volume":"101","author":"Danielpur","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jns.2022.120267_bb0230","first-page":"1","article-title":"Efficacy of GLP-1 agonist therapy in autosomal dominant WFS1-related disorder: a case report","author":"Scully","year":"2020","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.jns.2022.120267_bb0235","doi-asserted-by":"crossref","first-page":"9239530","DOI":"10.1155\/2016\/9239530","article-title":"Exenatide is an effective Antihyperglycaemic agent in a mouse model of Wolfram syndrome 1","volume":"2016","author":"Sedman","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"4","key":"10.1016\/j.jns.2022.120267_bb0240","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00125-009-1270-6","article-title":"Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice","volume":"52","author":"Akiyama","year":"2009","journal-title":"Diabetologia."},{"issue":"2018","key":"10.1016\/j.jns.2022.120267_bb0245","first-page":"9412676","article-title":"Wolfram syndrome: a case report and review of clinical manifestations, genetics pathophysiology, and potential therapies","author":"Toppings","year":"2018","journal-title":"Case Rep. Endocrinol."},{"key":"10.1016\/j.jns.2022.120267_bb0250","author":"National Center for Biotechnology Information"},{"issue":"01","key":"10.1016\/j.jns.2022.120267_bb0255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0033-1357160","article-title":"Delayed recognition of Wolfram syndrome frequently misdiagnosed as type 1 diabetes with early chronic complications","volume":"122","author":"Zmyslowska","year":"2014","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"4","key":"10.1016\/j.jns.2022.120267_bb0260","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/practneurol-2018-002057","article-title":"The swollen optic nerve: an approach to diagnosis and management","volume":"19","author":"Margolin","year":"2019","journal-title":"Pract. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2022.120267_bb0265","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.survophthal.2019.11.001","article-title":"Mitochondrial disorders and the eye","volume":"65","author":"Kisilevsky","year":"2020","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jns.2022.120267_bb0270","doi-asserted-by":"crossref","unstructured":"El-Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol. Genet. Metab. 2015 Sep-Oct;116(1\u20132):4\u201312.","DOI":"10.1016\/j.ymgme.2015.06.004"},{"issue":"2","key":"10.1016\/j.jns.2022.120267_bb0275","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/WNO.0000000000000340","article-title":"Visual, ocular motor, and Cochleo-vestibular loss in patients with Heteroplasmic, maternally-inherited diabetes mellitus and deafness (MIDD), 3243 transfer RNA mutation","volume":"36","author":"Cardenas-Robledo","year":"2016","journal-title":"J. Neuroophthalmol."},{"issue":"9 Pt 1","key":"10.1016\/j.jns.2022.120267_bb0280","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-134-9_Part_1-200105010-00008","article-title":"Maternally inherited diabetes and deafness: a multicenter study","volume":"134","author":"Guillausseau","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2022.120267_bb0285","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1177\/0883073812448230","article-title":"Clinical features of Friedreich ataxia","volume":"27","author":"Delatycki","year":"2012","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jns.2022.120267_bb0290","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archneur.64.4.558","article-title":"Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up","volume":"64","author":"Riba\u00ef","year":"2007","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2022.120267_bb0295","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s12020-021-02643-y","article-title":"Alstr\u00f6m syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity","volume":"71","author":"Dassie","year":"2021","journal-title":"Endocrine."},{"key":"10.1016\/j.jns.2022.120267_bb0300","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-3-319-95046-4_33","article-title":"Ciliopathy: Bardet-Biedl syndrome","volume":"1085","author":"Tsang","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jns.2022.120267_bb0305","series-title":"GeneReviews\u00ae [Internet]","first-page":"1993","article-title":"Cockayne syndrome","author":"Laugel","year":"2000"},{"key":"10.1016\/j.jns.2022.120267_bb0310","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-3-319-95046-4_35","article-title":"Ciliopathy: Alstr\u00f6m syndrome","volume":"1085","author":"Tsang","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.jns.2022.120267_bb0315","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.braindev.2016.08.012","article-title":"Infantile neuroaxonal dystrophy and PLA2G6-associated neurodegeneration: an update for the diagnosis","volume":"39","author":"Iodice","year":"2017","journal-title":"Brain Dev."},{"key":"10.1016\/j.jns.2022.120267_bb0320","series-title":"GeneReviews\u00ae [Internet]","first-page":"1993","article-title":"Deafness-dystonia-optic neuronopathy syndrome","author":"Tranebj\u00e6rg","year":"2003"},{"key":"10.1016\/j.jns.2022.120267_bb0325","series-title":"GeneReviews\u00ae [Internet]","first-page":"1993","article-title":"Charcot-marie-tooth neuropathy X type 5","author":"Kim","year":"2008"},{"issue":"Pt 1","key":"10.1016\/j.jns.2022.120267_bb0330","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/brain\/awr323","article-title":"The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy \u2018plus\u2019 phenotype","volume":"135","author":"Rouzier","year":"2012","journal-title":"Brain."},{"issue":"1","key":"10.1016\/j.jns.2022.120267_bb0335","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.25723","article-title":"ATPase domain AFG3L2 mutations Alter OPA1 processing and cause optic neuropathy","volume":"88","author":"Caporali","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2022.120267_bb0340","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40673-015-0038-7","article-title":"Spinocerebellar ataxia 28: a novel AFG3L2 mutation in a German family with young onset, slow progression and saccadic slowing","volume":"2","author":"Z\u00fchlke","year":"2015","journal-title":"Cerebellum Ataxias."},{"issue":"10","key":"10.1016\/j.jns.2022.120267_bb0345","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1093\/brain\/awx219","article-title":"Mutations in DNM1L, as in OPA1, result in dominant optic atrophy despite opposite effects on mitochondrial fusion and fission","volume":"140","author":"Gerber","year":"2017","journal-title":"Brain."},{"issue":"Pt 10","key":"10.1016\/j.jns.2022.120267_bb0350","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1093\/brain\/aws240","article-title":"Spastic paraplegia gene 7 in patients with spasticity and\/or optic neuropathy","volume":"135","author":"Klebe","year":"2012","journal-title":"Brain."},{"issue":"2","key":"10.1016\/j.jns.2022.120267_bb0355","doi-asserted-by":"crossref","first-page":"fcab063","DOI":"10.1093\/braincomms\/fcab063","article-title":"European ION group, Lenaers G. dominant ACO2 mutations are a frequent cause of isolated optic atrophy","volume":"3","author":"Charif","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.jns.2022.120267_bb0360","doi-asserted-by":"crossref","unstructured":"Okamoto, N., Miya, F., Hatsukawa, Y., et al. Siblings with optic neuropathy and RTN4IP1 mutation. J. Hum. Genet. 2021; 62: 927\u2013929, 2017.","DOI":"10.1038\/jhg.2017.68"},{"issue":"8","key":"10.1016\/j.jns.2022.120267_bb0365","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1097\/IAE.0000000000003054","article-title":"A rod-cone dystrophy is systematically associated to the RTN4IP1 recessive optic atrophy","volume":"41","author":"Meunier","year":"2021","journal-title":"Retina."},{"key":"10.1016\/j.jns.2022.120267_bb0370","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12881-019-0795-x","article-title":"Novel likely pathogenic variants in TMEM126A identified in non-syndromic autosomal recessive optic atrophy: two case reports","volume":"20","author":"Kloth","year":"2019","journal-title":"BMC Med. Genet."},{"issue":"5","key":"10.1016\/j.jns.2022.120267_bb0375","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ajhg.2015.09.012","article-title":"Recessive mutations in RTN4IP1 cause isolated and syndromic optic neuropathies","volume":"97","author":"Angebault","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.jns.2022.120267_bb0380","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ajhg.2009.03.003","article-title":"TMEM126A, encoding a mitochondrial protein, is mutated in autosomal-recessive nonsyndromic optic atrophy","volume":"84","author":"Hanein","year":"2009","journal-title":"Am. J. Hum. Genet."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22001290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22001290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:59:01Z","timestamp":1758383941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X22001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":76,"alternative-id":["S0022510X22001290"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2022.120267","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuro-ophthalmological manifestations of Wolfram syndrome: Case series and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2022.120267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120267"}}